|Antisepsis||Developed by Dr Adam Bray 2023, this document is a guide for information only. Local decisions must be made after consultation with your microbiology, infection control, theatre, and pharmacy teams as appropriate for your clinical setting and governance arrangements.||BSDS Guidance on Antisepsis (PDF)|
|Antithrombotics and Skin Surgery||The BSDS have produced guidance on bleeding risk and skin surgery: anticoagulants, antiplatelets and other agents. (updated 2023)|
|Sustainability Guidance 2022||
The British Society of Dermatological Surgery recognises the contribution of skin surgery and patient pathways to climate change. Dermatological surgery plays both a role in the unfolding ecological crisis and is equally affected through the consequent direct and indirect strain on its own service.
The BSDS Sustainability Guidance includes concise recommendations to allow health professionals to integrate sustainability into their local practice, as well as the evidence-base behind it.
|BSDS Sustainability Guidance 2022|
Management of patients with CIEDs around the time of surgery
(Including pacemakers and defibrillators)
The 2017 BSDS guidance has been replaced with a new flowchart and section for Dermatological surgery added to the British Heart Rhythm Society (BHRS) national guideline, which covers all types of surgery on patients with pacemakers and other implanted cardiac devices. This includes important pathway simplifications, such as when to switch off implanted defibrillators, and how to use magnets safely. These changes can facilitate better access to local surgery for patients. Other safety recommendations are reinforced. A summary of the key points has been accepted as a letter to the journal Clinical and Experimental Dermatology. We are very grateful to our Cardiology colleagues at the BHRS for working with us to update and combine these two guidelines.
Dermatology: Dr Adam Bray and Dr Mariel James
Cardiology: Dr Honey Thomas, Dr Andy Turley and Dr Chris Plummer
|British Heart Rhythm Society Guidelines for the Management of Patients with Cardiac Implantable Electronic devices (CIEDs) Around the Time of Surgery|
|Staffing and health facilities guidance for Dermatological Units||Clinical service / staffing and facilities guidance|
|BSDS Position Statement on Surgical Procedure Rooms||The BSDS has produced a position statement with effect from May 2016, outlining the evidence for a safe working environment within the outpatient or office based setting.||Infection Control Position Statement
Infection Statement Evidence
|BSDS Surgical Check List||The BSDS has produced a checklist to provide professionals with guidance on which checks need to be completed before and after a dermatological surgical procedure.||Checklist V1 , January 2012|
|DFSP Position Statement||The BSDS has produced a position statement with effect from December 2011 regarding the management of Dermatofibrosarcoma Protuberans (DFSP).||DFSP position statement|
|NICE Accredited Service Guidance and Standards For Mohs Micrographic Surgery (MMS)||Together with the British Association of Oral and Maxillofacial Surgeons, Royal College of Pathologists, British Society of Dermatopathology, British Oculoplastic Surgery Society and ENT UK we have produced these standards for Mohs surgery after a long period of development, multi-stakeholder involvement and consultation defining gold standard practice for MMS within the UK, as accredited by the National Institute for Health and Care Excellence (NICE).||
|Mohs Surgery Minimum Data Set||Dr Colin Fleming, Co-opted Interface Representative for the BSDS, has devised a Mohs Surgery Minimum Data Set which seeks to put into place a basic measurement of care which can be used for individual departmental audit and comparison amongst centres.||Mohs Surgery Data Capture Sheet (V2 February 2013)
Mohs Surgery Data Capture Sheet guidance notes
Skin Cancer Published Guidelines